Abstract: Use of benzydamine and physiologically acceptable acid addition salts thereof for preparing a medicament for the treatment of pathological conditions caused by TNF.
Abstract: A therapeutic method comprising treating a patient suffering from a neurodegenerative disease with a therapeutically effective quantity of a p-aminophenol derivative.
Abstract: A pharmaceutical composition comprising an anti-inflammatory drug capable of suppressing the production of cytokines (CSAID) an immunosuppressant and a pharmaceutically acceptable excipient.
Abstract: (S) or (R) enantiomer of a compound of formula: ##STR1## where Alk is an alkyl having from 1 to 3 carbon atoms, and an acid addition salt thereof with a physiologically acceptable acid.
Abstract: (S) or (R) enantiomer of a compound of formula: ##STR1## where Alk is an alkyl having from 1 to 3 carbon atoms, and an acid addition salt thereof with a physiologically acceptable acid.
Abstract: (S) or (R) enantiomer of a compound of formula: ##STR1## where Alk is an alkyl having from 1 to 3 carbon atoms, and an acid addition salt thereof with a physiologically acceptable acid.